Veloxis Pharmaceuticals: Konkurrencegodkendelser opnået for Asahi Kasei Pharma Denmarks offentlige overtagelsestilbud for aktier og warrants i Veloxis Pharmaceuticals
January 09, 2020 10:36 ET
|
Veloxis Pharmaceuticals A/S
Selskabsmeddelelse nr. 1/2020 Til: NASDAQ Copenhagen A/S København, Danmark, 9. januar 2020 Veloxis Pharmaceuticals: Konkurrencegodkendelser...
Veloxis Pharmaceuticals: Competition approvals obtained for the public tender offer by Asahi Kasei Pharma Denmark for the shares and warrants in Veloxis Pharmaceuticals
January 09, 2020 10:36 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 1/2020 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 09 January 2020 Veloxis Pharmaceuticals: Competition approvals obtained...
Karl Naegler joins Wellington Partners as Managing Partner
January 08, 2020 06:03 ET
|
Wellington Partners
MUNICH, Germany, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Wellington Partners, a leading European venture capital firm investing in early- and growth-stage life science companies, today announced that Dr....
Calibre Scientific Acquires NeXtal Biotechnologies to Further Expand its Protein Portfolio
January 08, 2020 06:00 ET
|
CalibreScientific, Inc.
LOS ANGELES, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce that it has completed the acquisition of the NeXtal Biotechnologies line of structural biology products from...
Taconic Biosciences Announces New San Diego Location
January 02, 2020 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the availability of both commercial animal...
Veloxis Pharmaceuticals Announces Financial Calendar for 2020
December 30, 2019 10:50 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 23/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 30 December 2019 Veloxis Pharmaceuticals Announces...
Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark har nu modtaget accepter fra aktionærer og warrantindehavere til at opfylde betingelsen om minimumskrav for accept
December 17, 2019 13:16 ET
|
Veloxis Pharmaceuticals A/S
Selskabsmeddelelse nr. 22/2019 Til: NASDAQ Copenhagen A/S København, Danmark, 17. december 2019 Veloxis Pharmaceuticals: Asahi Kasei Pharma...
Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark announces it has now received acceptances from shareholders and warrantholders to meet minimum acceptance condition
December 17, 2019 13:16 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 22/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 17 December 2019 Veloxis Pharmaceuticals: Asahi Kasei Pharma...
BioRestorative Therapies Featured in IEEE Pulse Magazine’s Cover Story About Stem Cell Therapies for Low Back Pain
December 16, 2019 08:00 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Dec. 16, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
BioRestorative Therapies Receives Patent in Israel For Its Metabolic Program
December 12, 2019 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Dec. 12, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...